
Sleeping Aids Market Report 2026
Global Outlook – By Product (Mattresses And Pillows, Sleep Laboratories, Medications, Prescription-Based Drugs, OTC Drugs, Herbal Drugs, Sleep Apnea Devices), By Indication (Insomnia, Sleep Deprivation, Narcolepsy, Sleep Apnea, Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce, Drug Stores, Other Distribution Channels) - Market Size, Trends, And Global Forecast 2026-2035
Sleeping Aids Market Overview
• Sleeping Aids market size has reached to $95.12 billion in 2025 • Expected to grow to $137.07 billion in 2030 at a compound annual growth rate (CAGR) of 7.6% • Growth Driver: Aging Population Catalyst For Soaring Growth In Sleeping Aid Market • Market Trend: EnsoData And React Health's Partnership Elevates Pap Adherence Support • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Sleeping Aids Market?
Sleeping aids refer to a class of psychoactive medications that are used to treat insomnia and sporadic sleeplessness. Sleeping aids can help decrease daytime tiredness and impaired thinking caused by sleep loss. The main types of sleeping aids are mattresses and pillows, sleep laboratories, medications, prescription-based drugs, OTC drugs, herbal drugs, and sleep apnea devices. ‘Medications’ refer to a formulation containing one or more active and/or inactive ingredients. The various indications include insomnia, sleep deprivation, narcolepsy, sleep apnea, and others. These are distributed through hospital pharmacies, retail pharmacies, e-commerce, sleep aids, drug stores, and others.
What Is The Sleeping Aids Market Size and Share 2026?
The sleeping aids market size has grown strongly in recent years. It will grow from $95.12 billion in 2025 to $102.13 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising insomnia prevalence, increased work-related stress, urban lifestyle changes, growth in otc drug availability, awareness campaigns on sleep disorders.What Is The Sleeping Aids Market Growth Forecast?
The sleeping aids market size is expected to see strong growth in the next few years. It will grow to $137.07 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to aging demographics, growth in wearable sleep devices, rising digital therapeutics adoption, increased diagnosis rates, innovation in natural sleep aids. Major trends in the forecast period include increased use of OTC sleep supplements, integration of AI-based sleep tracking, growth of non-habit-forming formulations, rising demand for home-based sleep therapy, expansion of online pharmacy channels.Global Sleeping Aids Market Segmentation
1) By Product: Mattresses And Pillows, Sleep Laboratories, Medications, Prescription-Based Drugs, OTC Drugs, Herbal Drugs, Sleep Apnea Devices 2) By Indication: Insomnia, Sleep Deprivation, Narcolepsy, Sleep Apnea, Other Indications 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, E-Commerce, Drug Stores, Other Distribution Channels Subsegments: 1) By Mattresses And Pillows: Memory Foam Mattresses, Latex Mattresses, Airbed Mattresses, Waterbed Mattresses, Cervical Pillows, Contoured Pillows 2) By Sleep Laboratories: Sleep Disorder Diagnostic Services, Polysomnography, Home Sleep Testing Services 3) By Medications: Prescription-Based Drugs, Over-The-counter (OTC) Drugs, Herbal And Natural Remedies 4) By Prescription-Based Drugs: Benzodiazepines, Non-Benzodiazepines, Antidepressants, Antihistamines 5) By OTC Drugs: Antihistamines (Diphenhydramine, Doxylamine), Melatonin Supplements, Herbal Sleep Aids 6) By Herbal Drugs: Valerian Root, Chamomile, Lavender, Passionflower, Lemon Balm 7) By Sleep Apnea Devices: Continuous Positive Airway Pressure (CPAP) Devices, Bi-level Positive Airway Pressure (BiPAP) Devices, Adaptive Servo-Ventilation (ASV) Devices, Oral Appliances, MasksWhat Is The Driver Of The Sleeping Aids Market?
The increasing global aging population is expected to propel the growth of the sleeping aid market going forward. The aging population is used to describe shifts in a population's age distribution that result in a higher percentage of elderly people. There is a growing need for sleep-related solutions due to the various aging-related factors that can cause sleep disorders and disturbances, thus, the need for sleeping aids is largely driven by the aging population. For instance, in May 2024, according to the Administration for Community Living, a US-based government agency, in 2022, 17.3% of the population was 65 or older. This percentage is expected to increase to 22% by 2040. Therefore, the increasing global aging population is driving the growth of the sleeping aid industry.Key Players In The Global Sleeping Aids Market
Major companies operating in the sleeping aids market are Cadwell Industries Inc., Compumedics Limited, DeVilbiss Healthcare Pvt. Ltd., Natus Medical Incorporated, Sleepmed Inc., ResMed Inc., Fisher & Paykel Healthcare Corporation Limited, Braebon Medical Corporation, Löwenstein Medical GmbH & Co. KG, Koninklijke Philips N.V., Apnea Sciences Corp., BMC Medical Co. Ltd., Cleveland Medical Devices Inc., Serta Simmons Bedding LLC, Tempur Sealy International Inc., Sleep Number Corporation, Casper Sleep Inc., Purple Innovation Inc., Leesa Sleep LLC, Lowenstein MedicalGlobal Sleeping Aids Market Trends and Insights
Major companies involved in the manufacturing of sleeping aids are focused on strategic collaboration with major manufacturing companies to strengthen their position in the market. Strategic collaborations empower companies to forge alliances with other firms possessing the necessary expertise to transform their envisioned concepts into tangible realities. For instance, in October 2023, EnsoData, Inc., a US-based software company and provider of artificial intelligence (AI) solutions to aid in sleep testing, diagnosis, and treatment, announced a strategic partnership with React Health, a US-based sleep and respiratory device manufacturing company, to maximize PAP adherence support for patients with sleep apnea. Through this partnership, suppliers of durable medical equipment and referring doctors will be able to access actionable data that will enable them to offer patients who are having difficulty adhering to their treatment plans prompt, individualized support.What Are Latest Mergers And Acquisitions In The Sleeping Aids Market?
In October 2025, Alkermes Plc, a Ireland-based biopharmaceutical company, acquired Avadel Pharmaceuticals, for $2.1 billion. With this acquisition, Alkermes aims to expand its presence in the sleep medicine market, strengthen its product portfolio with Avadel’s late-stage pipeline, and leverage combined R&D capabilities to accelerate the development and commercialization of innovative therapies for sleep disorders. Avadel Pharmaceuticals is an Ireland-based specialty pharmaceutical company focused on developing and commercializing treatments for sleep disorders.Regional Outlook
North America was the largest region in the sleeping aids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Sleeping Aids Market?
The sleeping aids market consists of sales of insomnia treatment drugs, quazepam, narcolepsy treatment drugs, modafinil, and sodium oxybate. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Sleeping Aids Market Report 2026?
The sleeping aids market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sleeping aids industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Sleeping Aids Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $102.13 billion |
| Revenue Forecast In 2035 | $137.07 billion |
| Growth Rate | CAGR of 7.4% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Indication, Distribution Channel |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Cadwell Industries Inc., Compumedics Limited, DeVilbiss Healthcare Pvt. Ltd., Natus Medical Incorporated, Sleepmed Inc., ResMed Inc., Fisher & Paykel Healthcare Corporation Limited, Braebon Medical Corporation, Löwenstein Medical GmbH & Co. KG, Koninklijke Philips N.V., Apnea Sciences Corp., BMC Medical Co. Ltd., Cleveland Medical Devices Inc., Serta Simmons Bedding LLC, Tempur Sealy International Inc., Sleep Number Corporation, Casper Sleep Inc., Purple Innovation Inc., Leesa Sleep LLC, Lowenstein Medical |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
